Twin Focus Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,054
| Closed | -$274K | – | 137 |
|
|
2024
Q1 | $274K | Sell |
5,054
-400
| -7% | -$21.7K | 0.05% | 122 |
|
|
2023
Q4 | $280K | Buy |
5,454
+180
| +3% | +$9.24K | 0.06% | 125 |
|
|
2023
Q3 | $306K | Sell |
5,274
-3,098
| -37% | -$180K | 0.07% | 118 |
|
|
2023
Q2 | $535K | Buy |
8,372
+2,566
| +44% | +$164K | 0.11% | 107 |
|
|
2023
Q1 | $402K | Buy |
5,806
+51
| +0.9% | +$3.54K | 0.08% | 124 |
|
|
2022
Q4 | $414K | Buy |
5,755
+41
| +0.7% | +$2.95K | 0.09% | 116 |
|
|
2022
Q3 | $406K | Hold |
5,714
| – | – | 0.1% | 107 |
|
|
2022
Q2 | $440K | Hold |
5,714
| – | – | 0.1% | 110 |
|
|
2022
Q1 | $417K | Buy |
5,714
+130
| +2% | +$9.49K | 0.08% | 130 |
|
|
2021
Q4 | $348K | Buy |
5,584
+1,022
| +22% | +$63.7K | 0.07% | 147 |
|
|
2021
Q3 | $270K | Buy |
4,562
+44
| +1% | +$2.6K | 0.06% | 146 |
|
|
2021
Q2 | $302K | Buy |
+4,518
| New | +$302K | 0.07% | 138 |
|
|
2021
Q1 | – | Sell |
-3,717
| Closed | -$231K | – | 164 |
|
|
2020
Q4 | $231K | Buy |
+3,717
| New | +$231K | 0.07% | 140 |
|
|
2020
Q2 | – | Sell |
-7,795
| Closed | -$434K | – | 150 |
|
|
2020
Q1 | $434K | Buy |
7,795
+104
| +1% | +$5.79K | 0.2% | 75 |
|
|
2019
Q4 | $494K | Buy |
7,691
+1,985
| +35% | +$127K | 0.16% | 102 |
|
|
2019
Q3 | $289K | Buy |
+5,706
| New | +$289K | 0.11% | 110 |
|